Elagolix Completed Phase 2 Trials for Endometriosis, Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00619866An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis